Cholangiocarcinoma, also known as bile duct cancer, is a rare disease. It's a devastating condition incurable at the point ...

Cholangiocarcinoma is a relatively rare adenocarcinoma of the bile ducts that is rapidly fatal unless it can be completely resected. In most cases, the tumor is too advanced for resection by the ...

Cholangiocarcinoma, known more commonly as bile duct (or biliary) cancer, has several features that historically have made it difficult to treat. First, it is a rare cancer, so advances in treatment ...

With a baby on the way, Nathan Kirkland was facing a rare, aggressive form of bile duct cancer. Kirkland’s bills piled up as ...

Results showed that across 3,038 U.S. counties there were 85,909 cholangiocarcinoma cases and 23,902 cholangioscopies performed — an annual mean volume of 2.5 (standard deviation, 7.1 ...

Across the 3 cholangiocarcinoma subtypes, OS of more than 3 years was associated with lower percentages of PD-1+ cells among the CD8+ T cells than those with OS of less than 3 years.

Optimism Remains as Cholangiocarcinoma Becomes the ‘Poster Child’ for Targeted Therapy Even though cholangiocarcinoma is a rare cancer, Valle said that he is still optimistic about the future of the ...

Intraductal neoplasms of the bile duct are macroscopically characterized by exophytic or polypoid growth patterns and have a favorable prognosis. Although some tumors with a predominantly tubular ...

Fortune Feimster revealed that her mother Ginger was diagnosed with Intrahepatic Cholangiocarcinoma, a rare and aggressive form of bile duct cancer. She said a mass the size of a small orange was ...

Final results from a phase II study of infigratinib (BGJ398), an FGFR-selective tyrosine kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma harboring an FGFR2 gene ...

World Cholangiocarcinoma Day is on February 15. We will celebrate progress on better diagnostics, treatment options, early detection and cures.